![1]()
News
Age leads COVID-19 hospitalization risk factors in RMDs
June 10, 2020
Glucocorticoid use, cardiovascular comorbidity, and male gender were also found to increase the risk of hospitalization from COVID-19 in inflammatory rheumatic diseases.
![1]()
News
Most rheumatology drugs don’t increase COVID-19 hospitalization risk
June 4, 2020
“These results provide, for the first time, information about the outcome of COVID-19 in patients with rheumatic and musculoskeletal diseases.”
![1]()
News
TNF inhibitors may dampen COVID-19 severity
May 19, 2020
New findings from the COVID-19 Global Rheumatology Alliance Registry.
News
Advice on treating rheumatic diseases from a COVID-19 epicenter
May 13, 2020
Hospital for Special Surgery rheumatologists discuss their approach to caring for patients with rheumatic diseases within their practice during the COVID-19 pandemic.
![1]()
News
ACR gives guidance on rheumatic disease management during pandemic
May 12, 2020
When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be stopped or held.
![1]()
News
Case series suggests biologics, JAK inhibitors safe during pandemic
May 1, 2020
Investigators saw no increase in hospitalizations versus the general population in New York City.
![1]()
News
Latest data on COVID-19 patients with rheumatic diseases revealed in registry
April 23, 2020
Data for a total of 583 COVID-19 patients have now been made available.
![1]()
News
‘We’re in great distress here,’ infusion center CMO says
April 10, 2020
Thrivewell is also deploying a mobile infusion unit to recovered COVID-19 patients who require an infusion for their autoimmune disease.
![1]()
News
Perioperative infliximab does not increase serious infection risk
February 6, 2017
The timing of a last dose of infliximab prior to elective knee or hip replacement surgery does not appear to affect the 30-day risk of serious infection after surgery.
